Search Results - "Prusila, Roosa E. I."

R‐bendamustine in the treatment of nodular lymphocyte predominant Hodgkin lymphoma—An extended follow‐up by Vuolio, Tero, Kuittinen, Outi, Väyrynen, Juha P., Teppo, Hanna‐Riikka, Prusila, Roosa E. I., Rämet, Maria, Kuitunen, Hanne, Paloneva, Timo, Kuusisto, Milla E. L.

Get full text

Mortality among patients with low‐grade follicular lymphoma: A binational retrospective analysis by Rajamäki, Aino, Hujo, Mika, Sund, Reijo, Prusila, Roosa E. I., Kuusisto, Milla E. L., Kuitunen, Hanne, Jantunen, Esa, Mercadal, Santiago, Sorigue, Marc, Sancho, Juan‐Manuel, Sunela, Kaisa, Kuittinen, Outi

“…Background The life expectancy of patients with follicular lymphoma (FL) has improved considerably since the introduction of rituximab. This study examined the…”
Get full text

Risk of secondary haematological malignancies in patients with follicular lymphoma: an analysis of 1028 patients treated in the rituximab era by Prusila, Roosa E. I., Sorigue, Marc, Jauhiainen, Jyrki, Mercadal, Santiago, Postila, Aleksi, Salmi, Petteri, Tanhua, Taru, Tikkanen, Susanna, Kakko, Sakari, Kuitunen, Hanne, Pollari, Marjukka, Nystrand, Ilja, Kuusisto, Milla E. L., Vasala, Kaija, Jantunen, Esa, Korkeila, Eija, Karihtala, Peeter, Sancho, Juan‐Manuel, Turpeenniemi‐Hujanen, Taina, Kuittinen, Outi

“…Summary Follicular lymphoma (FL) is the most common indolent lymphoma. Currently there are many comparable treatment options available for FL. When selecting…”
Get full text

Link between disease status at 24 months and mortality in follicular lymphoma by Rajamäki, Aino, Hujo, Mika, Sund, Reijo, Prusila, Roosa E. I., Kuusisto, Milla E. L., Kuitunen, Hanne, Jantunen, Esa, Mercadal, Santiago, Sorigue, Marc, Sancho, Juan‐Manuel, Kuittinen, Outi, Sunela, Kaisa

Get full text

Progression-free survival after front line, second line and third line in patients with follicular lymphoma treated in clinical practice by Rajamaki, Aino, Sorigue, Marc, Prusila, Roosa E I, Kuusisto, Milla E L, Kuitunen, Hanne, Jantunen, Esa, Mercadal, Santiago, Turpeenniemi-Hujanen, Taina, Sancho, Juan-Manuel, Sunela, Kaisa, Kuittinen, Outi

“…The modern-day therapeutic landscape for follicular lymphoma (FL) includes a number of highly effective therapies. We set out to determine progression-free…”
Get full text

Female patients with follicular lymphoma have a better prognosis if primary remission lasts over 24 months by Rajamäki, Aino, Sunela, Kaisa, Prusila, Roosa E. I., Kuusisto, Milla E. L., Mercadal, Santiago, Selander, Tuomas, Kuitunen, Hanne, Pollari, Marjukka, Jantunen, Esa, Nystrand, Ilja, Sancho, Juan-Manuel, Sorigue, Marc, Kuittinen, Outi

“…Findings regarding the role of sex in follicular lymphoma (FL) are contradictory and the prognostic value of sex among patients with early progression of…”
Get full text

Estimating the Lifetime Treatment Burden of Patients With Follicular Lymphoma: A Retrospective Study Using Real-World Multicenter Data by Rajamäki, Aino, Hujo, Mika, Sund, Reijo, Prusila, Roosa E I, Kuusisto, Milla E L, Kuitunen, Hanne, Jantunen, Esa, Mercadal, Santiago, Sorigue, Marc, Sancho, Juan-Manuel, Sunela, Kaisa, Kuittinen, Outi

“…Although follicular lymphoma is characterized by long natural history and frequent relapses, data on the number of patients receiving subsequent therapy lines…”
Get more information

Link between disease status at 24months and mortality in follicular lymphoma by Rajamäki, Aino, Hujo, Mika, Sund, Reijo, Roosa E I Prusila, Kuusisto, Milla E L, Kuitunen, Hanne, Jantunen, Esa, Mercadal, Santiago, Sorigue, Marc, Juan‐Manuel Sancho, Kuittinen, Outi, Sunela, Kaisa

Get full text

Incidence of solid cancer in patients with follicular lymphoma by Sorigue, Marc, Prusila, Roosa E I, Jauhiainen, Jyrki, Mercadal, Santiago, Postila, Aleksi, Salmi, Petteri, Tanhua, Taru, Tikkanen, Susanna, Kakko, Sakari, Kuitunen, Hanne, Pollari, Marjukka, Nystrand, Ilja, Kuusisto, Milla E L, Vasala, Kaija, Jantunen, Esa, Korkeila, Eija, Karihtala, Peeter, Sancho, Juan-Manuel, Turpeenniemi-Hujanen, Taina, Kuittinen, Outi

“…Patients with follicular lymphoma (FL) have classically had a higher risk of solid cancers than the general population, but there is little data available in…”
Get more information